News & Updates

Belly fat tied to musculoskeletal pain but not structural osteoporosis

19 Mar 2020

Visceral fat is associated with a heightened risk of musculoskeletal and widespread pain, according to a study.

Belly fat tied to musculoskeletal pain but not structural osteoporosis

19 Mar 2020

SPIRIT-P1: Ixekizumab suitable for long-term treatment of psoriatic arthritis

17 Mar 2020 by

Ixekizumab induces early and durable improvements in psoriatic arthritis (PsA) patients naïve to biological disease-modifying antirheumatic drugs (bDMARDs), with response occurring as early as week 1 and persisting throughout 3 years of treatment without incremental safety risks, according to the results of the phase III SPIRIT-P1* trial.

SPIRIT-P1: Ixekizumab suitable for long-term treatment of psoriatic arthritis

17 Mar 2020

CVD risk greater among arthritic vs diabetic patients

16 Mar 2020

The risk of cardiovascular (CV) disease (CVD) is significantly higher among patients with rheumatoid arthritis (RA) than those with type 2 diabetes (T2D), results of the CARRÉ* study reveal. Such risk persisted even after adjusting for traditional CV risk factors, which suggests that systemic inflammation is an independent contributor to CV risk.

CVD risk greater among arthritic vs diabetic patients

16 Mar 2020

Statin exposure following THA/TKA reduces risk of revision arthroplasty

15 Mar 2020

The risk of revision arthroplasty can be reduced by initiating statin therapy up to 5 years following total hip/knee arthroplasty (THA/TKA), suggests a recent study.

Statin exposure following THA/TKA reduces risk of revision arthroplasty

15 Mar 2020

$Denosumab increases BMD, cuts fracture risk in osteoporosis patients with diabetes$

Denosumab increases BMD, cuts fracture risk in osteoporosis patients with diabetes

13 Mar 2020

Treatment with denosumab in patients with osteoporosis and diabetes yields a substantial increase in bone mineral density (BMD) and a reduction in the risk of vertebral, but not nonvertebral, fractures, a study has found.

Denosumab increases BMD, cuts fracture risk in osteoporosis patients with diabetes

13 Mar 2020

Vitamin D deficiency implicated in lumbar disc degeneration, lower back pain in women

13 Mar 2020

Postmenopausal women with vitamin D deficiency are at greater odds of having lumbar disc degeneration (LDD) and low back pain (LBP), with a serum vitamin D concentration of <10 ng/mL being a marker of severe LDD and LBP, as reported in a recent study.

Vitamin D deficiency implicated in lumbar disc degeneration, lower back pain in women

13 Mar 2020

CD40-CD154 blockade pivotal in Sjögren’s syndrome treatment?

11 Mar 2020 by

The novel nondepleting, anti-CD40 monoclonal antibody iscalimab showed preliminary signs of efficacy in patients with primary Sjögren’s syndrome (SjS), a study has shown.

CD40-CD154 blockade pivotal in Sjögren’s syndrome treatment?

11 Mar 2020

Tocilizumab improves outcomes in patients with Takayasu arteritis

06 Mar 2020

A long-term course of once-weekly tocilizumab in patients with Takayasu arteritis appears to exert a steroid-sparing effect and yields improvements in well-being without raising new safety concerns, according to data from the Takayasu Arteritis Treated with Tocilizumab trial.

Tocilizumab improves outcomes in patients with Takayasu arteritis

06 Mar 2020

Leflunomide shows promise in Takayasu arteritis

06 Mar 2020 by

Use of the conventional DMARD* leflunomide led to rapid induction and sustained remission rates in patients with Takayasu arteritis (TA) especially in refractory cases, an observational study shows.

Leflunomide shows promise in Takayasu arteritis

06 Mar 2020

Low-dose IL-2 may render therapeutic benefit for SLE

05 Mar 2020 by

Low-dose interleukin (IL)-2 therapy may be effective for the treatment of active systemic lupus erythematosus (SLE), a study has shown.

Low-dose IL-2 may render therapeutic benefit for SLE

05 Mar 2020

News & Updates

Filter by Specialty:

Specialty:

Belly fat tied to musculoskeletal pain but not structural osteoporosis

Belly fat tied to musculoskeletal pain but not structural osteoporosis

SPIRIT-P1: Ixekizumab suitable for long-term treatment of psoriatic arthritis

SPIRIT-P1: Ixekizumab suitable for long-term treatment of psoriatic arthritis

CVD risk greater among arthritic vs diabetic patients

CVD risk greater among arthritic vs diabetic patients

Statin exposure following THA/TKA reduces risk of revision arthroplasty

Statin exposure following THA/TKA reduces risk of revision arthroplasty

Denosumab increases BMD, cuts fracture risk in osteoporosis patients with diabetes

Denosumab increases BMD, cuts fracture risk in osteoporosis patients with diabetes

Vitamin D deficiency implicated in lumbar disc degeneration, lower back pain in women

Vitamin D deficiency implicated in lumbar disc degeneration, lower back pain in women

CD40-CD154 blockade pivotal in Sjögren’s syndrome treatment?

CD40-CD154 blockade pivotal in Sjögren’s syndrome treatment?

Tocilizumab improves outcomes in patients with Takayasu arteritis

Tocilizumab improves outcomes in patients with Takayasu arteritis

Leflunomide shows promise in Takayasu arteritis

Leflunomide shows promise in Takayasu arteritis

Low-dose IL-2 may render therapeutic benefit for SLE

Low-dose IL-2 may render therapeutic benefit for SLE